ArticleInvestigational new drugs2021

Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells.

Hanbing Ning et al.PubMed ↗Publisher ↗

No numbers read from the abstract.